Maść Ichtiolowa (Ichthammol)

Ichthammol exerts its effect by releasing sulfur‑based compounds that possess anti‑inflammatory and antibacterial properties. These compounds inhibit prostaglandin synthesis and bacterial enzymes, which reduces inflammation, limits bacterial growth, and promotes mild keratolysis to aid removal of dead tissue.

The exact amount and frequency of application are determined by the prescribing healthcare professional. Typically, a thin layer is applied to the affected area two to three times daily, but the prescriber may adjust the regimen based on the severity of the condition and patient response.

Safety data for ichthammol use during pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Compared with topical antibiotics such as mupirocin, ichthammol offers both antibacterial and anti‑inflammatory actions, making it useful for mixed‑type lesions. Unlike corticosteroids, it does not carry the same risk of skin atrophy, but it may be less potent for severe inflammatory conditions.

Store the ointment at room temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, direct sunlight and extreme temperatures. Keep the container tightly closed when not in use to maintain product stability.

Apply a thin layer of the ointment to the cleaned, dry skin area affected by the condition. Gently massage until it is absorbed. Wash your hands before and after application, unless the hands are the treatment site.

The most serious risks include severe allergic reactions such as swelling, hives or anaphylaxis, extensive skin necrosis, and secondary infections caused by overgrowth of resistant organisms. Patients should discontinue use and seek medical attention if any of these occur.

Individuals with a known hypersensitivity to ichthammol or any component of the ointment should avoid its use. It is also contraindicated on large areas of broken skin, on mucous membranes, and in infants younger than two years unless specifically directed by a clinician.